GLUL and breast cancer: Additionally, luminal breast cancers have lower glutamine dependency, partly due to the luminal transcription factor GATA3, which can directly induce high expression of glutamine synthetase (GS), catalyzing the ATP-dependent reaction for de novo glutamine synthesis (Issaq et al., 2019; Kim et al., 2021).